HONG KONG, Afrilu 12, 2024 - (ACN Newswire) - Nasarar da Shoplazza ya samu kwanan nan na Kyautar Kasuwancin Mai Sauri a Kyautar Kasuwancin Kasuwancin Asiya Pacific (APEA) yana zama shaida ga rawar da yake takawa wajen canza hanyoyin kasuwancin E-commerce na B2C. Wannan babbar lambar yabo tana jaddada sadaukarwar Shoplazza ga ƙirƙira da ƙwarewar fasaha, musamman bayyananne a cikin samfurin sa na flagship, Siyayyar Katin SaaS.
Bikin APEA, wanda galibi ake masa lakabi da lambar yabo ta Oscar na kasuwancin Asiya, a kwanan baya ne aka kammala reshen kasar Sin a birnin Shanghai, inda ya nuna fa'ida da hadewar yanayin yanayin kasuwanci na yankin. Kasuwancin Asiya ne suka shirya shi, APEA ta fito a matsayin babban dandalin karrama fitattun shuwagabanni da kasuwanci a duk faɗin Asiya, tare da ƴan kasuwa da kamfanoni sama da 2,000 da aka amince dasu tun farkon sa.
Taken wannan shekara, 'Karfafa Asiya ta hanyar Tsarin Haɗin Kan Kasuwanci,' yayi dai-dai da manufar Shoplazza na haɓaka ci gaban tattalin arziki mai dorewa da haɓaka ci gaban zamantakewa. Ta hanyar ƙarfafa 'yan kasuwa daga wurare daban-daban da al'ummomi, Shoplazza yana da nufin buše yuwuwar da ba a iya amfani da su ba, fitar da sabbin abubuwa, da ƙirƙirar damammaki ga kowa.
Shoplazza, babban gidan wutar lantarki na duniya a cikin hanyoyin kasuwancin E-kasuwanci na B2C, da alfahari yana ba da sanarwar nasararsa ta kwanan nan a matsayin mai karɓar babbar lambar yabo ta Fast Enterprise. Wannan yabo yana sake tabbatar da ƙwarin gwiwar Shoplazza don ƙirƙira da ƙwarewar fasaha, musamman ta hanyar samfurin flagship ɗin sa, Siyayyar Cart SaaS, wanda ke ba wa 'yan kasuwa mafita-matakin kasuwanci don samun nasara kan layi.
Shoplazza's Shopping Cart SaaS babban dandamali ne wanda aka sani don jigogi da za a iya gyara shi, ingantaccen tsarin sarrafa tsari, manyan abubuwan tallan tallace-tallace, amintattun matsuguni, da fasalulluka na tallan imel. An amince da fiye da 'yan kasuwa 360,000 a cikin ƙasashe 150, Shoplazza yana aiki a matsayin mai haɓaka kasuwancin duniya, tare da Turai da Amurka ke lissafin kashi 40% na tushen mabukaci.
Gasar gasa ta Shoplazza ta fito ne daga ƙwararrun ƙwararrun injiniyoyinta, manyan gine-ginen Siyayyar Siyayya tare da buɗaɗɗen API, da ƙwarewar haɗa kai ta duniya. Waɗannan abubuwan suna tabbatar da saurin tura aikace-aikacen, dacewar na'urar mara misaltuwa, da gyare-gyare mara kyau wanda aka keɓance da buƙatun ɗan kasuwa ɗaya.
Bugu da ƙari, Shoplazza ya ƙirƙira dabarun haɗin gwiwa tare da manyan dandamali na kafofin watsa labarai na ketare kamar Google, Facebook, TikTok, da Snapchat. Waɗannan haɗin gwiwar suna ba 'yan kasuwa damar sarrafawa da haɓaka tallace-tallace kai tsaye daga dandalin Shagon Shagon da ke da hankali, yana haɓaka isar su da haɗin kai tare da masu sauraro masu niyya.
Bugu da ƙari, Shoplazza yana ba da keɓaɓɓen sabis don masu siyar da mai da hankali, gami da sabis na abokin ciniki kai tsaye zuwa Abokin ciniki (DTC) da sabis na aikin wakili. Waɗannan sabis ɗin suna ba 'yan kasuwa damar mai da hankali kan dabarun tallan kasuwanci na dogon lokaci, da kwarin gwiwa kan tallafin Shoplazza don buƙatun su na aiki.
A sa ido gaba, Shoplazza ya ci gaba da jajircewa kan wasu muhimman matakai guda biyu: tallafawa kamfanonin kasar Sin wajen yin kwafin nasarorin da suka samu a cikin gida a fagen duniya da samar da wani dandali mai sadaukarwa ga 'yan kasuwa na duniya don shiga kasuwanni daban-daban. Waɗannan yunƙurin suna nuna sadaukarwar Shoplazza na haƙiƙa don haɓaka haɓaka kasuwancin duniya da sabbin abubuwa a cikin yanayin kasuwancin E-kasuwanci.
Maudu'i: Takaitaccen sakin labaru
Sassa: Kasuwanci & eCommerce
https://www.acnnewswire.com
Daga Asusun Kamfanin Labarai na Asiya
Hakkin mallaka © 2024 ACN Newswire. Duk haƙƙoƙi. Rukunin Kamfanin Sadarwa na Asiya na Asiya.
- Ƙunshin Ƙarfafa SEO & Rarraba PR. Samun Girma a Yau.
- PlatoData.Network Tsaye Generative Ai. Karfafa Kanka. Shiga Nan.
- PlatoAiStream. Web3 Mai hankali. Ilmi Ya Faru. Shiga Nan.
- PlatoESG. Carbon, CleanTech, Kuzari, Muhalli, Solar, Gudanar da Sharar gida. Shiga Nan.
- PlatoHealth. Biotech da Clinical Trials Intelligence. Shiga Nan.
- Source: https://www.acnnewswire.com/press-release/english/90239/
